[go: up one dir, main page]

EP1561507A1 - Système pour caractériser un fluide, dispositif microfluidique pour caractériser ou analyser les composants de concentrations, une méthode de caractériser ou d'analyser de telles concentrations et un dispositif de mesure - Google Patents

Système pour caractériser un fluide, dispositif microfluidique pour caractériser ou analyser les composants de concentrations, une méthode de caractériser ou d'analyser de telles concentrations et un dispositif de mesure Download PDF

Info

Publication number
EP1561507A1
EP1561507A1 EP04075257A EP04075257A EP1561507A1 EP 1561507 A1 EP1561507 A1 EP 1561507A1 EP 04075257 A EP04075257 A EP 04075257A EP 04075257 A EP04075257 A EP 04075257A EP 1561507 A1 EP1561507 A1 EP 1561507A1
Authority
EP
European Patent Office
Prior art keywords
fluid
microfluidic device
reaction chamber
anyone
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04075257A
Other languages
German (de)
English (en)
Inventor
Sergi Gasso Pons
Michael Schlüter
Michael Franciscus Wilhelmus Cornelis Martens
Leon Maria Jacobus Wilhelmus Swinkels
Anton Wilhelmus Marie Van Wijk
Sebastian Mammitzsch
Franciscus Maria Anna Rosmalen
George Henry Parsons
Hans Jochen Lilienhof
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Future Diagnostics BV
Original Assignee
Future Diagnostics BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Future Diagnostics BV filed Critical Future Diagnostics BV
Priority to EP04075257A priority Critical patent/EP1561507A1/fr
Priority to PCT/NL2005/000061 priority patent/WO2005070533A1/fr
Publication of EP1561507A1 publication Critical patent/EP1561507A1/fr
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502707—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the manufacture of the container or its components
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06—Fluid handling related problems
    • B01L2200/0689—Sealing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/06—Auxiliary integrated devices, integrated components
    • B01L2300/0627—Sensor or part of a sensor is integrated
    • B01L2300/0636—Integrated biosensor, microarrays
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/0874—Three dimensional network
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/0883—Serpentine channels
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0887—Laminated structure
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00—Moving or stopping fluids
    • B01L2400/04—Moving fluids with specific forces or mechanical means
    • B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0433—Moving fluids with specific forces or mechanical means specific forces vibrational forces
    • B01L2400/0439—Moving fluids with specific forces or mechanical means specific forces vibrational forces ultrasonic vibrations, vibrating piezo elements
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00—Moving or stopping fluids
    • B01L2400/04—Moving fluids with specific forces or mechanical means
    • B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
    • B01L2400/0481—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure squeezing of channels or chambers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00—Moving or stopping fluids
    • B01L2400/04—Moving fluids with specific forces or mechanical means
    • B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
    • B01L2400/0487—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/50273—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the means or forces applied to move the fluids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502738—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by integrated valves

Definitions

  • the present invention relates a system for characterising a fluid, comprising a microfluidic device and a measurement device, to the microfluidic device, to the measurement device, to the method of characterising or analysing a concentration of a component.
  • Analytic detection of particles, molecules and especially biomolecules is fundamental to diagnostics as well as to molecular biology. In many applications, it is desirable to detect the presence of at least one particular molecule in a sample. Analytic detection is also used, e.g., in disease diagnosis and drug development, to determine the presence of a particular antibody or protein, e.g., in a blood sample or large chemical library. Detection of particles, molecules and biomolecules is therefore of fundamental value in, e.g., diagnostic medicine, archaeology, anthropology and criminal investigation.
  • US-A-6,444,461 discloses integrated systems, apparatus, software, and methods are provided for performing biochemical analyses, including DNA sequencing, genomic screening, purification of nucleic acids and other biological components and drug screening.
  • Microfluidic devices, systems and methods for using these devices and systems for performing a wide variety of fluid operations are provided.
  • the devices and systems are used in performing fluid operations that require a large number of iterative, successive or parallel fluid manipulations, in a microscale, or sealed and readily automated format.
  • US-A-6,235,175 discloses microfluidic devices that incorporate improved recess and reservoir geometries, as well as methods of using these devices in the analysis, preparation, or other manipulation of fluid borne materials, to achieve higher throughputs of such materials through these devices, with lower cost, material and/or space requirements. It is mainly aimed at improved recess and reservoir geometries. This is necessary as the dimensions are relatively small, that is in the order of 1-100 ⁇ m.
  • US-A-6,479,299 discloses microfluidic devices having predisposed assay components for increased throughput and prolonged shelf life. The methods involve flowing a first component of a biochemical system in a first of the at least two intersecting recesses.
  • At least a first test compound is flowed from a second recess into the first recess whereby the test compound contacts the first component of the biochemical system. An effect of the test compound on the biochemical system is then detected. It uses electrokinetic flow.
  • US-A-6,613,581 discloses methods of detecting a component of interest, such as a protein, in a microfluidic system. The methods include the use of a component-binding moiety specific to the component of interest, such as an antibody, to detect the component of interest. Also included are microfluidic devices and integrated systems for performing such assays, including devices utilizing flowable or fixed particle sets.
  • US-A-6,644,944 discloses microfluidic fluid control devices.
  • microfluidic fluid control device can be used as a uni-directional valve within a microfluidic system.
  • Said US- A-6,644,944 also teaches a microfluidic pump mechanism having two unidirectional valves separated by an expandable reservoir.
  • Such devices may be formed in multiple layers and utilize flexible membranes.
  • US-A-6,408,878 discloses a method of fabricating an elastomeric structure, comprising: forming a first elastomeric layer on top of a first micromachined mold, the first micromachined mold having a first raised protrusion which forms a first recess extending along a bottom surface of the first elastomeric layer; forming a second elastomeric layer on top of a second micromachined mold, the second micromachined mold having a second raised protrusion which forms a second recess extending along a bottom surface of the second elastomeric layer; binding the bottom surface of the second elastomeric layer onto a top surface of the first elastomeric layer such that a control recess forms in the second recess between the first and second elastomeric layers; and positioning the first elastomeric layer on top of a planar body such that a flow recess forms in the first recess between the first elastomeric layer and the planar
  • US-A-6,086,740 discloses multiplexed microfluidic devices including a plurality of modular microfluidic elements, all of which are attached to a common frame or body, which itself includes one or more common input elements that are connected to corresponding input elements within several or each of the microfluidic modules for use in common control and/or common detection operations for each of the modules.
  • the state of the art is aimed at very small structures (containing typically less than 10 ⁇ l fluid). Disadvantages of such small structures are that fluids tend to clog and/or that upon flow bubbles in the fluid may be formed.
  • the body used does not comprise recesses on several of its surfaces, e.g. on both sides of a card-like body. This makes it difficult to separate or position functions, such as a pumping function from a chamber function.
  • a next disadvantage is that when electrokinetic flow is applied, it will typically function sub-optimally, that is the components do not flow according as intended. Amongst others electroosmotic flow interferes with the electrokinetic flow.
  • Another disadvantage is that the flow can not be controlled sufficiently, especially the amount of fluid to be flown as well as the velocity of the flow.
  • a next disadvantage is that the microfluidic devices of the state of the art are so small that they are difficult to handle.
  • a next disadvantage is that the characterisation of the components present in the microfluidic devices are difficult to be determined, as it is difficult to get access to components present and/or the measuring device to be used is not optimised for microfluidic devices.
  • microfluidic devices are relatively static systems. They allow for simple operations, that is typically reacting one fluid with another and typically only once.
  • microfluidic devices are in general not supplied with fluids, that may contain chemicals, and if so only a very limited set is present.
  • microfluidic devices mentioned above are not dedicated to specific uses. For instance they do not contain a moiety to which a label or component present can be bound.
  • the present invention relates a system for characterising a fluid, comprising a microfluidic device and a measurement device, to the microfluidic device, to the measurement device, to the method of characterising or analysing a concentration of a component.
  • the present invention relates to a system for characterising or analysing a fluid, which fluid is suspected to comprise at least one component to be characterised or analysed, comprising a microfluidic device, at least one pump for transporting the fluid and a measurement device which is arranged to characterise or analyse the fluid in use present in the microfluidic device, which microfluidic device comprises at least one body (11), wherein the body has at least one surface, wherein the at least one surface has at least a part of the recess for containing the fluid in the microfluidic device and/or transporting the fluid in the microfluidic device through at least a part of the microfluidic device, wherein the body has at least one provision for an inlet (15) and at least one provision for an outlet (18), wherein at least a part of said recess (16) is a reaction chamber, which reaction chamber comprises a moiety that binds to the at least one component that is suspected to be present and that is to be characterised or analysed, which reaction chamber is
  • a general layout of the microfluidic device is given in figure 1. It contains several recesses (14-17) on a body (11). The recesses are formed on both sides of the body.
  • the fluid to be characterised or measured is brought into the provision for an inlet (15). Then, it flows to the reaction chamber (16). In the reaction chamber, a component that is suspected to be present can bind to a moiety, present in the reaction chamber (16).
  • component refers to a component that itself binds to a label or a moiety present in the microfluidic device, or to a chemical part of that component, of which at least one part binds to a label or a moiety present, or to a component which is labeled in the microfluidic device, which labeled component binds to the moiety present in the microfluidic device, or to a component that causes a detectable signal by itself, by a chemical reaction with another component, or by a component formed here out, whereby the detectable signal may be chemiluminescent flash or flow, colorimetric, fluorescent and time-resolved fluorescent.
  • fluid refers to liquid compositions that flow at operating pressure and temperature.
  • pump refers to a combination of an actuator, a displacement volume and at least one means for transferring the variation in pressure of the actuator towards the displacement volume.
  • the means for transferring the variation can be a membrane.
  • the displacement volume is referred to as pump chamber.
  • the pump further comprises means for controlling the actuator.
  • the pump chamber typically has a volume of 1 -1000 ⁇ l, preferably of 10-100 ⁇ l.
  • inlet refers to a provision through which a fluid or a gas may pass.
  • the direction of the fluid or gas is intended to be from the environment to a recess. It typically has a volume of 1-1000 ⁇ l, preferably of 1-10 ⁇ l.
  • outlet refers to a provision through which a fluid or a gas may pass.
  • the direction of the fluid or gas is intended to be from a recess to the environment. It typically has a volume of 1-1000 ⁇ l, preferably from 1-10 ⁇ l.
  • fluid connection is a recess sealed by a cover layer. It is to be interpreted in a broad sense. Thus, it is not intended to be restricted to elongated configurations where the transverse or longitudinal dimension greatly exceeds the diameter or cross-sectional dimension. Rather, recesses are meant to comprise cavities and/or tunnels of any desired shape or configuration through which fluids may be directed.
  • a cavity may, for example, comprise a flow-through cell where fluid is to be continuously passed or, alternatively, a chamber for holding a specified, discrete amount of fluid for a specified amount of time.
  • a "fluid connection” may be filled or may contain internal structures comprising fluid diodes, valves or equivalent components. Its volume is from 1 to 1000 ⁇ l, preferably from 10-100 ⁇ l.
  • microfluidic as used herein is to be understood, without any restriction thereto, to refer to structures or devices through which fluid(s) are capable of being passed or directed, wherein one or more of the dimensions is less than 500 microns.
  • reces refers to a "fluid connection” type structure that is present on a surface of the body of the microfluidic device.
  • the body substantially surrounds it.
  • a recess in use is at least partly sealed by at least one cover layer, except for inlet and outlet provisions. It may also refer to part of a recess, especially in the case of chambers, meandering fluid path and fluid connection.
  • chamber refers to part of a covered recess in the body, which has a volume of 1-1000 ⁇ l, preferably of 10-100 ⁇ l. It is capable of for instance comprising a fluid, a binding-moiety etc. From the above it is clear that a chamber is also used as a fluid connection.
  • reaction chamber refers to a chamber used for reacting components and/or for binding at least one component to a moiety that is present in the reaction chamber. Furthermore, the reaction chamber can be arranged with the measurement device. It has a volume of 1-1000 ⁇ l, preferably of 10-100 ⁇ l, more preferably of 10-30 ⁇ l.
  • polishing fluid path refers to part of a fluid connection. It is a channel type part of a recess, which channel forms several bends. Hereby a relatively long channel occupies only a limited amount of surface on the microfluidic device. It has a volume of 1 -1000 ⁇ l, preferably of 10-500 ⁇ l, more preferably of 50-200 ⁇ l.
  • body refers to a solid material.
  • the solid material has at least one surface and can be of any shape. A preferred shape has the dimensions of a "credit-card". At least one surface of the body comprises at least a part of a recess.
  • the top and bottom side of the body comprise at least one recess.
  • the at least one recess of the topside is in fluid connection with the at least one recess of the bottom side.
  • the solid material should allow for manufacturing techniques to form recesses on the surface of the body. Such manufacturing techniques are for instance moulding, injecting moulding, hot embossing and lithographic processes, optionally combined with etching techniques.
  • the material preferably is stable and chemically resistent to the fluids used in the microfluidic device. It furthermore preferably has the desired physical properties, such as hydrophilicity and a smooth surface after manufacturing.
  • the material used as body is typically a polymer or silicon or glass.
  • a suitable polymer is selected from the group consisting of latex, rubber, polyesters, polycarbonates, polyalkanes, polyalkenes, polytetrafluoroethylenes, polypropylenes, polyimides, polymethylmethacrylates, silicones, polymethylmethacrylate (PMMA), PEEK, polystyrene, PDMS, and polyesters.
  • a preferred material is polymethylmethacrylate (PMMA).
  • cover layer refers to a material that is used to seal recesses from the environment.
  • the material used as cover layer is typically a polymer or silicon or glass.
  • a suitable polymer is selected from the group consisting of latex, rubber, polyesters, polycarbonates, polyalkanes, polyalkenes, polytetrafluoroethylenes, polypropylenes, polyimides, polymethylmethacrylates, silicones, polymethylmethacrylate (PMMA), PEEK, polystyrene, PDMS, and polyesters.
  • a preferred material is polymethylmethacrylate (PMMA).
  • the moiety that binds a component is attached to the cover layer, covering the reaction chamber.
  • This has the advantage that the moiety can be deposited on the cover layer, prior to covering the reaction chamber recess with this cover.
  • the cover layer (12) has an adhesive (22) to which the moiety (23) is attached.
  • the reaction chamber itself (16) is a recess in the body (11). Further, a second cover layer (13) is visible.
  • the moiety can be present in the form of magnetic and/or non-magnetic antibody coated particles.
  • the moiety that binds is chosen from the group consisting of a nuclear receptor, an intracellular receptor, a solubilized receptor, an antibody, an antigen, an enzyme, avidin, a polynucleotide and a polysaccharide.
  • the present invention has a first advantage that it can optimally use the surface of the body, e.g. both sides of a credit-card shaped body, to form recesses. This makes it possible to separate various functions of the system, such as the pump function and the receiving function.
  • the energy transfer is located at one side of the body and the provision for an inlet and the reaction chamber are located on the other side.
  • the pump function generally requires a relative large amount of space, even with the micro-sized pumps that now become available.
  • the present invention is not particularly aimed at reducing the size; it rather provides a microfluidic device that is easy to operate.
  • the microfluidic device has size of that is similar to that of a credit card, e.g. 85 by 60 by 1 mm 3 .
  • the present invention further has the advantage that it provides a combination of a microfluidic device with a compatible measurement device.
  • the microfluidic device is filled with a fluid to be characterised or analysed. After the pump forces the fluid to flow from the pump chamber to the reaction chamber, the fluid can be characterised by the measuring device by arranging the microfluidic device with the measuring device.
  • the system of the invention comprises a measurement device for characterising the fluid, wherein the measurement device is arranged to obtain information based on an optical technique selected from the group consisting of fluorescence, chemiluminescence, time resolved fluorescence, time resolved chemiluminescence, colorimetry or a combination thereof, or from the group consisting of magnetic measurements, resistivity measurements, capacity measurements, surface plasma resonance (SPR) measurements, or a combination thereof.
  • This embodiment has the advantage that the measurement device can easily be arranged to the microfluidic device.
  • a preferred embodiment radiates the reaction chamber and detects emitted radiation.
  • An optical measurement device is arranged to obtain information based on a technique selected from the group consisting of fluorescence, chemiluminescence, time resolved fluorescence, or a combination thereof.
  • a preferred embodiment uses a fluorescence technique.
  • system of the invention characterises the concentration of at least one component present in the fluid.
  • it is used to characterise one component, which has the advantage that the system can be fully optimised to characterise this one component.
  • the moiety present in the reaction chamber, the wash fluid, the detection are optimised. It provides microfluidic devices comprising all necessary material in the device.
  • the system of the invention comprises at least one pump.
  • This pump can be present on the microfluidic device or in the measurement device.
  • this pump is a piezo-pump.
  • the present invention makes use of a piezo pump in a structure, which has as further advantage that it enables the fluid to be directed from a part of the recess to another recess.
  • the present invention further uses the piezo pump in order to perform all kinds of pumping functions, for instances to move fluids in controlled amounts form a part of the recess tot the other, to perform pumping cycles, to optimise piezo frequencies with respect to the dimensions of the recesses, to permit time intervals in between pumping etc.
  • the at least one piezo-pump preferably operates at a frequency up to 40 kHz.
  • the frequency may also be used to reverse the preferred flow direction of the fluid diode.
  • the system is disposable all together.
  • extreme situations such as emergency or war, there may be a need to identify the status of a patient on short notice, whereas the desire to maintain the measurement device is not an issue.
  • Such a disposable system has in such a situation the advantage of providing a dedicated and quick answer to the status of a patient.
  • a microfluidic device arranged for use in the system of the invention comprises at least one body (11), wherein the body has at least one surface, wherein the at least one surface has at least a part of the recess for containing the fluid in the microfluidic device and/or transporting the fluid in the microfluidic device through at least a part of the microfluidic device, wherein the body has at least one provision for an inlet (15) and at least one provision for an outlet (18), wherein at least a part of said recess (16) is a reaction chamber, which reaction chamber comprises a moiety that binds to the at least one component that is suspected to be present and that is to be characterised or analysed, which reaction chamber is arranged for characterising or analysing the at least one component, wherein at least a part of said recess is a fluid connection (14) between the at least one provision for an inlet (15) and the at least one provision for an outlet, wherein at least a
  • two cover layers form one part, which make it easier to seal the microfluidic device. This is an advantage in the manufacture of the microfluidic device.
  • the microfluidic device further comprises a filter in at least one provision for an inlet.
  • the filter is used to hold particles and/or components that adversely interfere in the characterisation or analyses of the fluid in the measurement device.
  • the filter is for instance a particle filter, such as a MilliporeTM filter with an intended hole-size, or a chemical compound that reacts or binds to undesired components, thereby immobilising these components.
  • the microfluidic device further comprises at least a part of the recess for a washing fluid and at least a part of the recess for collecting waste fluid.
  • the microfluidic device further comprises at least a part of the recess which comprises at least one label fluid, which label binds to the moiety in the reaction chamber and/or to the at least one component to be characterised or analysed.
  • FIG 3 such a layout is given. It shows a top view of the microfluidic device.
  • the bottom side of the microfluidic device comprises also a number of recesses. The bottom side is brought into an arrangement with the pump-actuator. A first glance at the figure immediately indicates the intense use of the surface of the body. Not only do reaction chamber(s) occupy space, but also the meandering fluid path type recesses do.
  • meandering fluid path type structures have the advantage that they contain a relative large volume on the side, which is combined with the possibility to flow very well controlled amounts of fluid on the other side.
  • a meandering fluid path type structure contains from 1-1000 ⁇ l of fluid.
  • a further advantage with respect to a chamber is that the meandering fluid path can be emptied almost completely, whereas a chamber always has some residual liquid. Further, the meandering fluid path has less leakage as compared to a chamber.
  • the fluid to be characterised is transferred to the provision for an inlet (15). This provision for an inlet is in fluid connection with the central reaction chamber (16). It is optional to have other reaction chambers present (16), which serve similar functions as the first chamber.
  • Fluid connections (33-35) are used to transfer the label fluid.
  • Fluid connections (36-38) are used to transfer the wash fluid.
  • Fluid connection (39) is used to collect the waste fluid.
  • FIG 4 shows a provision for an inlet (15), wherein the fluid to be characterised or analysed is injected.
  • the fluid is moved from the inlet (15) towards the reaction chamber (16) by means of a pump (17), located on the bottom side, in fluid connection with the front side.
  • the fluid diodes (40) provide for the desired flow direction of the fluids used.
  • the at least one provision for the outlet (18) is opened, in order to compensate for the volume of fluid moved.
  • the design of the provision for the inlet and the fluid connection towards the reaction chamber limit the back flow.
  • the design of the reaction chamber is such that it provides for optimal flow profiles, with minimised dead volume and optimised contact with the moiety present.
  • a large meandering fluid path is present for collecting the waste fluid from the reaction chamber. Also visible are fluid connections (19) between the bottom side and the top side of the microfluidic device.
  • label refers to a compound that can be detected directly or indirectly by the measuring the device. So it can also be a particle containing a label, such as a 3-dimensional structure with a label inside. Or it may be an enzyme that first may react with another component present. It also can form a bond with the moiety and/or at least one of the components present in the fluid. Preferred one or more of the following typically characterizes labels: high sensitivity, high stability, causing a low background signal upon detection, low environmental sensitivity and high specificity in labelling.
  • a preferred embodiment of the microfluidic device further comprises at least one provision for an inlet (15) which is arranged to receive the fluid, said inlet being sealed by a seal from the environment, which seal is to be removed upon use, thereby opening at least one entrance to the at least one provision for an inlet and/or which comprises at least one provision for an outlet (18) that is prior to use sealed from the environment by a seal, which seal is to be removed upon use.
  • This has the advantage that the microfluidic device has a prolonged shelf life.
  • the at least one provision for an outlet and the least one provision for an inlet will also be opened prior to use, the first to enable a fluid to flow, the latter to enable a sample to be inserted into the microfluidic device.
  • microfluidic device has a prolonged shelf life. Furthermore it is ready to use. And it can be used once and then disposed of. As it comprises a minimal amount of fluids the environmental impact is small.
  • a preferred embodiment of the microfluidic device further comprises at least one soft seal that closes at least a part of the recess.
  • soft seal refers to a seal that closes a part of the recess, thereby preventing liquid and/or gas to flow from this apart to another part.
  • the soft seal is broken upon applying a limited amount of force, such as the pressure or energy transferred by a pump.
  • the soft seal is selected from the group of fluids with relatively high viscosity.
  • Soft seal material can e.g. be selected from the group of silicones and silicone oils. The advantage of such a seal is clearly that is prevents leakage, not only in normal circumstances, but also for instance during transport of the device.
  • a preferred embodiment of the microfluidic device characterized in that at least one of the fluid connection(s) is equipped with fluid diodes for resisting a flow of the fluid through the fluid connections in one direction.
  • This fluid diodes (40) are also shown if figure 3.
  • a clear advantage of the use of such diodes it that it directs the flow of fluids in a desired direction, whereas it reduces the flow in the other direction significantly.
  • This has the further advantage that it enables the performance of more complicated reaction programs.
  • various fluids can be used, whereas without the diodes this would be much more complicated or even impossible.
  • a further advantage is that it allows for much more complex structures on (both sides) of the body, whereby many more fluid connections are made, without the fluids being undesirably mixed or flowed.
  • a further advantage is that recesses and/or chambers that comprise different fluids can be separated if required in one flow direction.
  • fluid diode refers to a structure within a recess, which is characterized in that the resistance to a fluid flow is significantly larger in one direction compared to the other and which has no moving parts. In other words, the resistance towards a fluid flow changes significantly with change in the direction of the flow. It further has the advantage that applying a different frequency from the actuator of the pump may reverse the preferred flow direction.
  • the fluid diodes have a brush-like or valve-like structure. The proper orientation of the brush structures is not intuitively obvious even to one skilled in the art. It rather must be determined with mathematical modelling of the fluid flow and by experimentation.
  • Figure 5 shows top view of a preferred embodiment of a fluid diode in a body (11).
  • the recess (14) contains brush like structures (51), which act as a resistance to the flow in one direction.
  • the arrow (53) indicates the flow direction that is not hindered. In that case, the fluid enters the fluid diode indicated with (52).
  • the fluid diode has a width of 1 mm.
  • the brushes are 0,5 mm long and 70 ⁇ m wide.
  • microfluidic device further comprises further elements for directing the fluid.
  • elements are for instance valves. This has the advantage that even more complex pumping operations and reaction sequences can be performed.
  • the microfluidic device further comprises a readable information carrier.
  • the readable information carrier is an optically or electrically readable information carrier, most preferably it is an electrically readable information carrier.
  • the information carrier may be detachable from the microfluidic device. As for example in emergency situations a measurement would be performed, thereby using a microfluidic device according to the invention. The result of the measurement may need to be logged into a central computer; therefore the results need to be transferred from the microfluidic device to the computer. The device itself may be contaminated and therefore needs to be disposed. A detachable information carrier thus allows for the desired transfer.
  • the readable information carrier contains data that is for instance relating to the microfluidic device and/or relating to a method of operating the microfluidic device and/or the system for characterising a fluid. It further provides operating instructions, such as pump frequencies. These instructions optimise the use of materials contained in the device, the time necessary to label the components of interest, the accuracy of the result obtained. It also provides measurement instructions, such as a pump times, intervals etc. It also contains data relevant to the device, such as intended use, and it contains data relevant to the measurement, such as type of device and calibration curve respectively. In another embodiment the information carrier just provides the measurement system with the intended use. This reference allows the measurement system then to retrieve and/or calculate the above-mentioned data and use it accordingly. This information present in the information carrier has the advantage that the use of the microfluidic device, in combination with the measurement device is very easy and can be performed by persons with limited skills and knowledge.
  • the microfluidic device further comprises labels.
  • these labels are selected from fluorescent labels, chemiluminescent labels and colorimetric labels.
  • the measurement device suitable for use in a system characterises a fluid in the microfluidic device of the present invention, which fluid is suspected to comprise at least one component to be characterised or analysed, which measurement device is associated to the microfluidic device
  • Figure 6 represents a schematic layout of the actual detection in the measurement device.
  • a light source (41) is used to radiate (42) a component present in the reaction chamber (16).
  • the light source is a laser.
  • a lens (43) may be used.
  • a component is present in the reaction chamber (16) that emits radiation (45)
  • this radiation can optionally be passed through a filter (46).
  • the component is or comprises a fluorescent label. If light is emitted it is detected by a detection unit (47).
  • the measurement device further comprises, at least one communication port for transferring data, at least one read-out unit for reading in characteristics of the microfluidic device, at least one light source illuminating the reaction chamber in the microfluidic device, at least one detection element for detecting the radiation emitted from the reaction chamber, an information unit displaying characteristics of the fluid.
  • the read-out unit allows for the information relating to the microfluidic device and the type of measurement to be transferred to the measuring device and subsequently to the data-collecting device, without any burden. The information safeguards the correct use of the measurement device and therefore also of the results obtained.
  • the unit that is associated with the microfluidic device furthermore provides for a simple to perform measurement.
  • the information unit provides for the opportunity to directly obtain a visual result that can be used in a subsequent action, such as treatment.
  • the measurement device will typically be used to characterise or analyse a component that is selected from the group consisting an antibody, a cell receptor, an antigen, a receptor ligand, an enzyme, a body, an immunochemical, an immunoglobulin, a virus, a virus binding component, a protein, a cellular factor, hormones, allergenics, a growth factor, an cell-inhibitor, DNA, RNA, antigen to be bound to an antibody or receptor or a combination thereof
  • the measurement device further comprises a communication port of an USB-type.
  • a communication port of an USB-type This is a standard interface for electronic devices, which allows for easy installation and easy data transfer. And it is economical.
  • the measurement device further comprises a chip-reader as the read-out unit.
  • a chip-reader as the read-out unit.
  • This is a standard interface for reading information on chips, which allows for easy installation and easy data transfer.
  • the read-out unit can also be used to write data on the chip.
  • This data comprises the result or results of the characterisation or analysis. This has the advantage that the information can later on be logged, for instance to a central computer facility. It can further comprise sample information and patient information. And it is economical.
  • the measurement device further comprises a laser as the light source.
  • a laser has the advantage of emitting nearly monochromatic light, though an option may be to use polychromatic (laser) light and use filters. The latter is preferably used in the case that the measurement device has a multipurpose use and/or is used to detect various wavelengths of emitted light at the same time. Also a laser can be easily replaced if necessary. It also is a reliable light source that consumes a low amount of energy.
  • the measurement device comprises a photodiode, a CCD, a photo multiplier tube (PMT) or a series of photodiodes as the detection element.
  • the detection element is capable of detecting the light that is emitted by the at least one component to be characterised or analysed.
  • the advantage of photodiodes or CCD is that they are quite specific with respect to the wavelength chosen.
  • the measurement device further comprises software.
  • the software is used for at least directing the at least one pump to transfer an external pressure to at least one of the chambers of the microfluidic device of the invention.
  • the software further provides for the information on the microfluidic device to be transferred to the measurement device and subsequently to perform the reaction sequence. It provides for the determination of the concentration of the at least one component suspected to be present in the fluid. It therefore provides for a simple operation procedure and minimises the risk for mistakes.
  • the measurement device may comprise a local memory and/or computing chip, in order to store and retrieve data as well as to perform calculations and to control the other components present.
  • the invention describes a method for characterising or analysing characterising or analysing at least one component that is suspected to be present in a fluid comprising,
  • the method comprises separating a mixture of components, which mixture of components may contain the components of interest.
  • the mixture of components or the separated components are contacted to a component-binding moiety specific to the component of interest.
  • the component-binding moiety binds to the component of interest and is detected, thereby detecting the component of interest, either by measuring the component-bonding moiety directly or by measuring the result of competition with other components, that have been replaced by the component of interest.
  • the embodiment of the present invention has the further advantage that the complete procedure can be performed on one microfluidic device and the measurement result can be obtained directly from the measurement device associated with it.
  • a component of interest is labelled with a detectable label, subsequently bound to the binding moiety and then detected.
  • the detection signal is then calculated to a concentration, using a calibration curve of the label.
  • the microfluidic device is in arrangement with a piezo-pump.
  • the piezo-pump is instructed to perform complicated pumping cycles, involving pumping a fluid, leaving the fluid to react and repeating such steps.
  • complex pumping cycles of one fluid are alternated with complex pumping cycles of another fluid. For instance, first a label fluid is moved to the reaction chamber with such a pumping cycle and subsequently a wash fluid, which steps are repeated if required.
  • reaction rate is to a large extend determined by the kinetics of the pumping, rather than by the movement of components in the fluid due to concentration gradients. This improves the reaction time as well as the sensitivity.
  • a further advantage is that the amount of fluid used are minimised with such a procedure. This has the further advantage that even more complicated pumping operations and reaction sequences can be performed.
  • the moiety can be present in the form of (magnetic and/or non-magnetic antibody) coated particles.
  • the particles are optionally stacked in a detection region.
  • the component-binding moiety thereby binds to the component of interest, thus providing detection of the component of interest.
  • the method comprises providing a body structure having a plurality of recesses disposed therein, the plurality comprising a microfluidic separation recess and at least one side recess intersecting the separation recess, wherein the separation recess and the side recess are fluidly coupled.
  • a mixture of components is flowed through the separation recess, resulting in separated components.
  • a labelled component-binding moiety is subsequently flown through a side recess and into the separation recess, wherein it binds to the component of interest. The component-binding moiety is then detected, thereby detecting the component of interest.
  • steps d and e are repeated a number of times.
  • step d This has the advantage that more label (step d) is bound to the moiety and thereby the emitted radiation in the detection steps is increased. Furthermore it allows to optimise the use of label fluid.
  • the method for characterising or analysing at least one component that is suspected to be present in a fluid comprises,
  • the characterising or analysing method further comprises the use of a fluorescent of chemiluminescent label.
  • the separated components are typically labelled components that are optionally detected simultaneously with the component-binding moiety.
  • This embodiment optionally includes deconvoluting the detection signal to identify the separated components and the component of interest.
  • This embodiment includes two detectably different label moieties having detectably different spectral characteristics, such as different excitation or emission maximum.
  • the different labels include, but are not limited to fluorescent labels, chemiluminescent labels and colorimetric labels.
  • the separated components are optionally labelled with a first fluorescent dye and the component-binding moiety is labelled with a second fluorescent dye. These two dyes are typically detectably different.
  • the component of interest and the component-binding moiety are optionally labelled with detectably different colorimetric labels.
  • the component of interest is labelled with one type of label, e.g., chemiluminescent
  • the component-binding moiety is labelled with a second type of label, e.g., fluorescent.
  • the characterising or analysing method the component to be characterised or analysed is selected from the group consisting an antibody, a cell receptor, an antigen, a receptor ligand, an enzyme, a body, an immunochemical, an immunoglobulin, a virus, a virus binding component, a protein, a cellular factor, hormones, allergenics, a growth factor, an cell-inhibitor, DNA, RNA, antigen to be bound to an antibody or receptor or a combination thereof.
  • the fluid is preferably a body fluid, such as a blood, serum, urine, saliva, or extracts, such as plant-extracts.
  • the characterising or analysing method further comprises the use of a laser as the light-source.
  • This example describes the measurement of myoglobin concentration in a blood sample.
  • a polymethylmethacrylate (PMMA)-microfluidic device containing Piezo-pumps is cleaned with ethanol (70%) followed by demineralised water.
  • the microfluidic device is completely dried by applying compressed air.
  • a piece of transparent foil with the same size as the microfluidic device (seals the recesses in the PMMA structure from the environment.
  • the foil is from Permacel, a Nitto Denko company). This way the microrecesses are closed.
  • a window in the foil was cut just over the reaction area, in order to be able to detect the light emitted by the label.
  • the diameter of the window is 3,6 mm, of which 3,5 mm is covered with nitrocellulose.
  • the depth of the chamber is about 450 ⁇ m.
  • Strips of polyester supported nitrocellulose were coated with Monoclonal mouse IgG anti human Myoglobin (Medix, Finland). Spots of 1 ⁇ l (1 ⁇ g Ab/ ⁇ l HEPES buffer pH 8) were dropped on to the nitrocellulose. The spots are dried at room temperature for 30 minutes. After this the nitrocellulose strips are blocked with a HEPES buffer + 0.1% Tween 20TM (from ICI, USA) at pH 8 for one hour. An additional drying step (4 hours at room temperature) is required before the strips are ready to use.
  • the polyester support of the nitrocellulose strip was mounted on a double-sided adhesive tape. After that the nitrocellulose side is covered with a transparent plastic foil to avoid any damage. From these strips dots of 35 mm are prepared by using a revolver punch gripper from Conrad. It should be taken into consideration that the coated antibody is in the centre of the 35 mm dot of nitrocellulose.
  • the protection foil and the double side adhesive tape are removed, and the polyester support side is put in the centre of to a 15x10 mm piece of Permacel foil. This foil is put in the window where the reaction area is located.
  • the nitrocellulose should face the PMMA structure, and it is located as close as possible to the outlet of the microrecess.
  • the PMMA reaction area has a diameter of 36 mm. The reaction area is sealed with the Permacel foil containing the piece of nitrocellulose.
  • the label and wash reservoirs are filled with their respective buffers. Both reservoirs are consisting of the chamber under the piezo-pump, the fluid diodes and the microrecesses, which are needed for a proper functioning.
  • the label solution is a HEPES based buffer (pH8) containing a biotinylated monoclonal antibody (anti Myoglobin) with the fluorescence labelled streptavidin (Molecular Probes).
  • the fluorescence signal is generated by a so-called Fluorescence Resonance Energy Transfer system. When the complex is excited at 635 nm it emits light at 778 nm.
  • a syringe is filled with sample (Myoglobin Std from SCIPAC (Scipac Ltd. Kent UK) diluted with HEPES buffer pH 8, at a concentration of 0 ng/ml, 100 ng/ml or 1000 ng/ml respectively and connected to the sample inlet from the microfluidic device.
  • sample Myoglobin Std from SCIPAC (Scipac Ltd. Kent UK) diluted with HEPES buffer pH 8, at a concentration of 0 ng/ml, 100 ng/ml or 1000 ng/ml respectively and connected to the sample inlet from the microfluidic device.
  • Piezo pumps are connected to the amplifier and the wash and label syringes were removed from the microfluidic device. At this stage, the microfluidic device was ready-to-use.
  • the wash-buffer After 5 seconds of pumping the wash-buffer the reaction area is soaked during 15 seconds.
  • the label fluid is refreshed eight times by 0,5 seconds pumping with 15 seconds diffusion in between.
  • the washing interval ends with 15 seconds of diffusion.
  • the openings for the wash, label and waste fluids are sealed with Permacel foil.
  • the sample syringe is removed and the sample inlet is also sealed with Permacel foil.
  • the piezo-pumps are disconnected and the piece of nitrocellulose including the labelled component is removed from the reaction chamber.
  • the piece of nitrocellulose is placed in a strip-holder (centre position, always in the same place) of the fluorescence reader from LRE Technology Partner GmbH and kept in the dark. After drying the nitrocellulose for 30 minutes it was read out with the LRE-Reader.
  • the reader excites the fluorescent label with a laser diode that emits at 642 nm, and a photodiode collecting the emitted light from the dye above 725 nm.
  • the slight difference in wavelength is caused by the difference between the theoretical value and the value actually used and/or obtained.
  • the fluorescence scanner obtains one value (in arbitrary fluorescence units) every 0.054 mm.
  • the results of the measurement are shown.
  • the first three peaks are three assays done on the same body, which were incubated with 0, 100, and 1000 ng/ml of Myoglobin, successively.
  • the second part of the figure shows a group of three peaks under identical conditions but on another body.
  • the detector determines the peak width.
  • the detector scans the nitrocellulose, each time generating a signal.
  • the maximum peak level increases with Myoglobin concentration.
  • the spots used were placed as a liquid on the nitrocellulose the peaks can be somewhat ⁇ -symmetrical.
  • the second series is somewhat different with respect to peak (height and width) as compared to the first series, which is due to statistical variation and reproducibility.
  • microfluidic device according to the present invention is produced by methods known to the person skilled in the art.
  • FIG. 4 An embodiment according to the invention consists out of a PMMA body (see figure 4).
  • Figure 4 shows the layout, though the dimensions shown herein are different in reality.
  • the size of this body is 60 by 47 by 1 mm 3 .
  • the recesses in the front side and back side of the body are manufactured by injection-moulding the PMMA body.
  • the fluid diodes are made by injection moulding.
  • the width of the fluid connections is about 1 mm, the depth is approximately 450 ⁇ m.
  • the diameter of the reaction chamber is about 4 mm.
  • the body consists out of one provision for an inlet. Also three provisions for an outlet are present, the first in connection with the meandering fluid path with the wash fluid, the second in connection with the meandering fluid path for collecting the waste fluid, and the third in connection with the meandering fluid path with the label fluid. It further contains fluid connections between the provision for the inlet and the reaction chamber, between the meandering fluid path for collecting the waste fluid and the reaction chamber, between the meandering fluid path with the wash fluid and the reaction chamber and between the meandering fluid path with the label fluid and the reaction chamber. Also is contains two pump chambers, one for pumping the label fluid and one for pumping the wash fluid. These pump chambers are connected to the wash fluid and label fluid by a fluid connection from one side of the body to the other. Further four fluid diodes are present for directing the fluid.
  • the cover layers are connected to the body by hot-welding PMMA. Before this hot-welding step a strip of nitrocellulose was place on the covering PMMA layer, in a location that it coincides with the reaction chamber.
  • the reaction chamber contains as a moiety monoclonal mouse IgG anti human Myoglobin.
  • This moiety was deposited on the cover layer prior to the hot-welding step. A drop of fluid containing the moiety was dripped on the nitrocellulose strip, of which the location also coincides with the reaction chamber.
  • the pumps used are readily available piezo-pumps.
  • the wash fluid used is demineralised water.
  • the label fluid solution is a HEPES based buffer (pH 8) containing a biotinylated monoclonal antibody (anti Myoglobin) with the fluorescence labelled streptavidin (Molecular Probes).
  • a preferred embodiment of the characterising or analysing device is constructed out of components that are readily available.
  • the housing of the measurement device can be constructed by injection-moulding.
  • the material used in the housing can be typically a polymer.
  • the communication ports used can be standard USB-interfaces, consisting out of USB-plugs and USB-sockets.
  • the read-in unit can be a standard chip-read-out unit, used for instance for banking-cards, which is widely available.
  • the receiving device can be a standard receiving unit, used for instance for the intake of banking-cards in an ATM, which is widely available.
  • the measurement device contains a laser.
  • a preferred laser can be a standard 635 nm laser, which is widely available. The type of laser and frequency used will clearly depend on the component that is suspected to be present and/or the label used.
  • the detection unit can be a standard 778 nm detection unit, which is widely available.
  • Typical voltage amplitudes applied to the piezo-pump are 150V and 300V.
  • the achieved pressure is from 200 to 4000 Pa, but may vary upon the piezo-pump used, the type of fluid diode and pumping altitude.
  • the information unit can be a standard LCD-display, which is widely available.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Clinical Laboratory Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)
EP04075257A 2004-01-27 2004-01-27 Système pour caractériser un fluide, dispositif microfluidique pour caractériser ou analyser les composants de concentrations, une méthode de caractériser ou d'analyser de telles concentrations et un dispositif de mesure Withdrawn EP1561507A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP04075257A EP1561507A1 (fr) 2004-01-27 2004-01-27 Système pour caractériser un fluide, dispositif microfluidique pour caractériser ou analyser les composants de concentrations, une méthode de caractériser ou d'analyser de telles concentrations et un dispositif de mesure
PCT/NL2005/000061 WO2005070533A1 (fr) 2004-01-27 2005-01-27 Systeme de caracterisation d'un fluide, dispositif microfluidique de caracterisation ou d'analyse de concentrations de constituants, procede de caracterisation ou d'analyse de telles concentrations, dispositif de mesure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04075257A EP1561507A1 (fr) 2004-01-27 2004-01-27 Système pour caractériser un fluide, dispositif microfluidique pour caractériser ou analyser les composants de concentrations, une méthode de caractériser ou d'analyser de telles concentrations et un dispositif de mesure

Publications (1)

Publication Number Publication Date
EP1561507A1 true EP1561507A1 (fr) 2005-08-10

Family

ID=34673703

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04075257A Withdrawn EP1561507A1 (fr) 2004-01-27 2004-01-27 Système pour caractériser un fluide, dispositif microfluidique pour caractériser ou analyser les composants de concentrations, une méthode de caractériser ou d'analyser de telles concentrations et un dispositif de mesure

Country Status (2)

Country Link
EP (1) EP1561507A1 (fr)
WO (1) WO2005070533A1 (fr)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008103824A1 (fr) * 2007-02-23 2008-08-28 Chinese Academy Of Inspection And Quarantine (Caiq) Immunoessai à l'or lié à un anticorps par point amélioré en sensibilité pour la détection de virus
US8021614B2 (en) 2005-04-05 2011-09-20 The General Hospital Corporation Devices and methods for enrichment and alteration of cells and other particles
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
US8168389B2 (en) 2006-06-14 2012-05-01 The General Hospital Corporation Fetal cell analysis using sample splitting
US8195415B2 (en) 2008-09-20 2012-06-05 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
US8304230B2 (en) 2002-09-27 2012-11-06 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
EP2817638B1 (fr) * 2012-02-23 2017-08-02 Services Pétroliers Schlumberger Système de mesure de la teneur en asphaltènes d'une huile brute a l'aide d'une puce microfluidique
CN107942050A (zh) * 2017-11-10 2018-04-20 南京岚煜生物科技有限公司 一种基于磁珠技术的微流控芯片检测方法
US10591391B2 (en) 2006-06-14 2020-03-17 Verinata Health, Inc. Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
US10704090B2 (en) 2006-06-14 2020-07-07 Verinata Health, Inc. Fetal aneuploidy detection by sequencing

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005059536B4 (de) * 2005-12-13 2008-08-28 Siemens Ag Verfahren und Biochip zur Untersuchung einer biologischen Probe
JP5091223B2 (ja) * 2007-02-23 2012-12-05 株式会社ブリヂストン 空気入りラジアルタイヤ
DE102009016712A1 (de) * 2009-04-09 2010-10-14 Bayer Technology Services Gmbh Einweg-Mikrofluidik-Testkassette zur Bioassay von Analyten
US8678305B2 (en) 2009-06-18 2014-03-25 Fellowes, Inc. Restrictive throat mechanism for paper shredders
CN102023142A (zh) * 2009-09-15 2011-04-20 福华电子股份有限公司 生物微流道检测装置及其分子检测方法
TWI711819B (zh) * 2012-07-16 2020-12-01 大陸商昌和生物醫學科技（揚州）有限公司 增強疾病檢測與鑒定的器件與方法
WO2016062788A1 (fr) 2014-10-24 2016-04-28 Ait Austrian Institute Of Technology Gmbh Puce microfluidique pour analyse biologique
CN113418898B (zh) * 2021-06-18 2022-10-28 贵州医科大学 一种pifo平台的由微流控芯片和荧光传感器组成的集成装置

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020123059A1 (en) * 2001-03-05 2002-09-05 Ho Winston Z. Chemiluminescence-based microfluidic biochip

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399023B1 (en) * 1996-04-16 2002-06-04 Caliper Technologies Corp. Analytical system and method
US6777245B2 (en) * 2000-06-09 2004-08-17 Advalytix Ag Process for manipulation of small quantities of matter
AU2002230418A1 (en) * 2000-11-06 2002-05-15 The Government Of The United States Of America, As Represented By The Secretary Of Health And Human Services Sample delivery system with laminar mixing for microvolume biosensing
JP2002214241A (ja) * 2000-11-20 2002-07-31 Minolta Co Ltd マイクロチップ
JP2002236131A (ja) * 2000-12-08 2002-08-23 Minolta Co Ltd マイクロチップ
WO2003015923A1 (fr) * 2001-08-20 2003-02-27 Biomicro Systems, Inc. Melange de fluides dans des chambres a faible rapport de forme
JP4221184B2 (ja) * 2002-02-19 2009-02-12 日本碍子株式会社 マイクロ化学チップ
WO2004065930A2 (fr) * 2003-01-14 2004-08-05 Micronics Inc. Dispositifs microfluidiques pour la manipulation et l'analyse de fluides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020123059A1 (en) * 2001-03-05 2002-09-05 Ho Winston Z. Chemiluminescence-based microfluidic biochip

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8304230B2 (en) 2002-09-27 2012-11-06 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US11052392B2 (en) 2002-09-27 2021-07-06 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US10081014B2 (en) 2002-09-27 2018-09-25 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US8986966B2 (en) 2002-09-27 2015-03-24 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US8372579B2 (en) 2002-09-27 2013-02-12 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US8895298B2 (en) 2002-09-27 2014-11-25 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US8021614B2 (en) 2005-04-05 2011-09-20 The General Hospital Corporation Devices and methods for enrichment and alteration of cells and other particles
US12409457B2 (en) 2005-04-05 2025-09-09 The General Hospital Corporation Devices and method for enrichment and alteration of cells and other particles
US10786817B2 (en) 2005-04-05 2020-09-29 The General Hospital Corporation Devices and method for enrichment and alteration of cells and other particles
US9956562B2 (en) 2005-04-05 2018-05-01 The General Hospital Corporation Devices and method for enrichment and alteration of cells and other particles
US8585971B2 (en) 2005-04-05 2013-11-19 The General Hospital Corporation Devices and method for enrichment and alteration of cells and other particles
US9174222B2 (en) 2005-04-05 2015-11-03 The General Hospital Corporation Devices and method for enrichment and alteration of cells and other particles
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US9273355B2 (en) 2006-06-14 2016-03-01 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
US8168389B2 (en) 2006-06-14 2012-05-01 The General Hospital Corporation Fetal cell analysis using sample splitting
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
US11781187B2 (en) 2006-06-14 2023-10-10 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
US9347100B2 (en) 2006-06-14 2016-05-24 Gpb Scientific, Llc Rare cell analysis using sample splitting and DNA tags
US11674176B2 (en) 2006-06-14 2023-06-13 Verinata Health, Inc Fetal aneuploidy detection by sequencing
US9017942B2 (en) 2006-06-14 2015-04-28 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
US10704090B2 (en) 2006-06-14 2020-07-07 Verinata Health, Inc. Fetal aneuploidy detection by sequencing
US10591391B2 (en) 2006-06-14 2020-03-17 Verinata Health, Inc. Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
US8372584B2 (en) 2006-06-14 2013-02-12 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
US10155984B2 (en) 2006-06-14 2018-12-18 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
WO2008103824A1 (fr) * 2007-02-23 2008-08-28 Chinese Academy Of Inspection And Quarantine (Caiq) Immunoessai à l'or lié à un anticorps par point amélioré en sensibilité pour la détection de virus
US8296076B2 (en) 2008-09-20 2012-10-23 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuoploidy by sequencing
US10669585B2 (en) 2008-09-20 2020-06-02 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
US8195415B2 (en) 2008-09-20 2012-06-05 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
US9404157B2 (en) 2008-09-20 2016-08-02 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
US9353414B2 (en) 2008-09-20 2016-05-31 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
US12054777B2 (en) 2008-09-20 2024-08-06 The Board Of Trustees Of The Leland Standford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
US8682594B2 (en) 2008-09-20 2014-03-25 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
EP2817638B1 (fr) * 2012-02-23 2017-08-02 Services Pétroliers Schlumberger Système de mesure de la teneur en asphaltènes d'une huile brute a l'aide d'une puce microfluidique
CN107942050A (zh) * 2017-11-10 2018-04-20 南京岚煜生物科技有限公司 一种基于磁珠技术的微流控芯片检测方法

Also Published As

Publication number Publication date
WO2005070533A1 (fr) 2005-08-04

Similar Documents

Publication Publication Date Title
US20230120417A1 (en) Kits And Devices For Detecting Analytes
EP1561507A1 (fr) Système pour caractériser un fluide, dispositif microfluidique pour caractériser ou analyser les composants de concentrations, une méthode de caractériser ou d'analyser de telles concentrations et un dispositif de mesure
US10775369B2 (en) Fluidic systems for analyses
US8831783B2 (en) Biochemical processing apparatus
EP2613881B1 (fr) Dispositif de dosage et lecteur
US11325120B2 (en) Specimen treatment chip, specimen treatment apparatus, and specimen treatment method
EP2610618A1 (fr) Dispositif microfluidique centrifuge et procédé de détection d'analytes dans un échantillon liquide
JP2002236131A (ja) マイクロチップ
WO2004062804A1 (fr) Biopuce microfluidique a moyens d'etancheite cassables
JP6871905B2 (ja) アッセイを実行するための流体システム
WO2007099736A1 (fr) Puce de micro-inspection, detecteur optique et systeme analytique micro-complet
KR20190000851A (ko) 랩온어칩, 랩온어칩 제조 방법 및 랩온어칩을 이용한 진단 방법
JP2007120399A (ja) マイクロ流体チップおよびマイクロ総合分析システム
JP2006284451A (ja) 検体中の標的物質を分析するためのマイクロ総合分析システム

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

AKX Designation fees paid
REG Reference to a national code

Ref country code: DE

Ref legal event code: 8566

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060211